Menu
← Oncology Approval Tracker
FDA DECISION ·
Pemetrexed Injection (Hospira)
pemetrexed · Hospira
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Pemetrexed injection for labeled nonsquamous NSCLC use with cisplatin, maintenance and previously treated settings, and cisplatin combination treatment of malignant pleural mesothelioma.
LAMPGEN ANALYSIS
Why it matters
This action adds a separately approved injection product for established thoracic oncology uses.
What research teams should watch
Distinguish this injection product from the vial that requires reconstitution and verify regimen-specific labeling.
PRIMARY RECORDS